{"id":"NCT00683852","sponsor":"Massachusetts General Hospital","briefTitle":"A Double-Blind, Placebo-Controlled Study of Aripiprazole Adjunctive to Antidepressant Therapy","officialTitle":"A Double-Blind, Placebo-Controlled Study of Aripiprazole Adjunctive to Antidepressant Therapy (ADT) Among Outpatients With Major Depressive Disorder Who Have Responded Inadequately to Prior ADT","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2008-09","primaryCompletion":"2009-09","completion":"2009-09","firstPosted":"2008-05-26","resultsPosted":"2017-07-19","lastUpdate":"2017-07-19"},"enrollment":225,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Major Depressive Disorder"],"interventions":[{"type":"DRUG","name":"Aripiprazole 5mg","otherNames":["Abilify"]},{"type":"DRUG","name":"Aripiprazole 2mg","otherNames":["Abilify"]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"Drug 2mg/Drug 5mg","type":"ACTIVE_COMPARATOR"},{"label":"Placebo/Drug 2mg","type":"ACTIVE_COMPARATOR"},{"label":"Placebo/Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"The purpose of this study is to determine whether a reduced dose of aripiprazole is effective in treating patients with major depressive disorder","primaryOutcome":{"measure":"MADRS (Montgomery-Asberg Depression Rating Scale) Response Rate","timeFrame":"12 weeks","effectByArm":[{"arm":"Phase 1 Drug","deltaMin":10,"sd":null},{"arm":"Phase 1 Placebo Non-Responders on Drug in Phase 2","deltaMin":11,"sd":null},{"arm":"Phase I Placebo","deltaMin":29,"sd":null},{"arm":"Phase 1 Placebo Non-Responders on Placebo in Phase 2","deltaMin":5,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":2,"exclusionCount":null},"locations":{"siteCount":1,"countries":["United States"]},"refs":{"pmids":["18344725","17592907","22286203","21939613"],"seeAlso":["https://www.ncbi.nlm.nih.gov/pubmed/22286203"]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":54},"commonTop":["Weight increased","Headache","Oedema peripheral","Diarrhoea","Insomnia"]}}